Nexalin Technology, Inc. Increase (Decrease) in Accounts Receivable
Nexalin Technology, Inc. (NXL) reported Increase (Decrease) in Accounts Receivable of -$28.64 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-12
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$27.89K, a 157.18% decline year-over-year.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$755.00, a 172.60% decline year-over-year.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $35.83K.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$51.92K, a 1171.76% decline year-over-year.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $33.72K.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $880.00.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$253.00, a 102.61% decline from fiscal 2021.
- Nexalin Technology, Inc. increase (decrease) in accounts receivable for fiscal 2021 was $9.70K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$27.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$28.64K 10-Q · filed 2026-08-12 | $7.19K derived: sum of 3 quarters · filed 2026-08-12 | -$44.72K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$755.00 10-Q · filed 2026-05-08 | $35.08K derived: sum of 2 quarters · filed 2026-05-08 | -$16.84K derived: sum of 3 quarters · filed 2026-05-08 | $31.93K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $35.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$16.08K derived: sum of 2 quarters · filed 2026-03-25 | $32.68K derived: sum of 3 quarters · filed 2026-08-12 | $33.72K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$51.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.15K derived: sum of 2 quarters · filed 2026-08-12 | -$2.11K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $48.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $49.80K 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $1.04K 10-Q · filed 2026-05-08 | |||
| 2024-09-30 | $4.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.36K derived: sum of 2 quarters · filed 2025-11-14 | $5.26K 10-Q · filed 2025-11-14 | -$3.47K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $518.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $418.00 10-Q · filed 2025-08-06 | -$8.31K derived: sum of 3 quarters · filed 2025-09-23 | -$8.15K derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | -$100.00 10-Q · filed 2025-05-13 | -$8.83K derived: sum of 2 quarters · filed 2025-09-23 | -$8.67K derived: sum of 3 quarters · filed 2025-09-23 | $2.10K derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | -$8.73K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | -$8.57K derived: sum of 2 quarters · filed 2025-09-23 | $2.21K derived: sum of 3 quarters · filed 2025-09-23 | $880.00 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $161.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $10.93K derived: sum of 2 quarters · filed 2024-11-08 | $9.61K 10-Q · filed 2024-11-08 | $4.13K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $10.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.45K 10-Q · filed 2024-08-08 | $3.97K derived: sum of 3 quarters · filed 2024-08-08 | -$9.37K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$1.32K 10-Q · filed 2024-05-10 | -$6.80K derived: sum of 2 quarters · filed 2024-05-10 | -$20.14K derived: sum of 3 quarters · filed 2024-05-10 | -$55.12K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$5.48K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$18.81K derived: sum of 2 quarters · filed 2024-03-27 | -$53.79K derived: sum of 3 quarters · filed 2024-03-27 | -$253.00 10-K · filed 2024-03-27 |
| 2022-09-30 | -$13.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$48.32K derived: sum of 2 quarters · filed 2023-11-13 | $5.22K 10-Q · filed 2023-11-13 | $4.66K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$34.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $18.56K 10-Q · filed 2023-08-10 | $18.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $53.54K 10-Q · filed 2023-05-10 | $52.98K derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2021-12-31 | -$564.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $9.70K 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $10.27K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |